JBC Focus on PI3-Kinase with Echelon

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kippen, A. D.
Right arrow Articles by Rose, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kippen, A. D.
Right arrow Articles by Rose, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 272, Number 19, Issue of May 9, 1997 pp. 12513-12522
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Development of an Isotope Dilution Assay for Precise Determination of Insulin, C-peptide, and Proinsulin Levels in Non-diabetic and Type II Diabetic Individuals with Comparison to Immunoassay

(Received for publication, December 5, 1996, and in revised form, February 19, 1997)

Alistair D. Kippen , Fabrice Cerini , Laszlo Vadas § , Reto Stöcklin , Lan Vu , Robin E. Offord and Keith Rose

From the Department of Medical Biochemistry, University Medical Centre and § Central Laboratory of Clinical Chemistry, University Hospital, 1211 Geneva 4, Switzerland

We describe the application of a stable isotope dilution assay (IDA) to determine precise insulin, C-peptide, and proinsulin levels in blood by extraction from serum and quantitation by mass spectrometry using analogues of each target protein labeled with stable isotopes. Insulin and C-peptide levels were also determined by immunoassay, which gave consistently higher results than by IDA, the relative difference being larger at low concentrations. Insulin, C-peptide, and proinsulin levels were all shown by IDA to be higher in type II diabetics than in non-diabetics, with mean values rising from 22 (± 2) to 92 (± 8), 335 (± 11) to 821 (± 24), and 6 (± 1) to 37 (± 3) pM, respectively. Interestingly, the ratio between IDA and immunoassay values for insulin levels increased from 1.3 in non-diabetics to 1.7 in type II diabetics. The ratio between proinsulin and insulin levels by IDA increased from 0.24 in non-diabetics to 0.36 in type II diabetics, whereas the ratio between C-peptide and insulin levels by IDA decreased from 17.6 to 10.7. This disproportionate change in protein levels between different types of individuals has implications for the metabolism of insulin in the diabetics studied (type II) and suggests that C-peptide levels are not always a reliable guide as to pancreatic insulin secretion. In addition, levels of the 33-residue C-peptide (partially trimmed form) were shown to be less than 10% that of the fully trimmed 31-residue C-peptide levels, and we tested IDA in a clinical context by two post-pancreatic graft studies. IDA was shown to give direct, positive identification of the target protein with unrivaled accuracy, avoiding many of the problems associated with present methodology for protein determination.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Clin. Chem.Home page
E. Rogatsky, B. Balent, G. Goswami, V. Tomuta, H. Jayatillake, G. Cruikshank, L. Vele, and D. T. Stein
Sensitive Quantitative Analysis of C-Peptide in Human Plasma by 2-Dimensional Liquid Chromatography-Mass Spectrometry Isotope-Dilution Assay
Clin. Chem., May 1, 2006; 52(5): 872 - 879.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
L. Anderson
Candidate-based proteomics in the search for biomarkers of cardiovascular disease
J. Physiol., February 15, 2005; 563(1): 23 - 60.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
R Gama, J D Teale, and V Marks
Best Practice No 173: Clinical and laboratory investigation of adult spontaneous hypoglycaemia
J. Clin. Pathol., September 1, 2003; 56(9): 641 - 646.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
C. Fierens, D. Stockl, D. Baetens, A. P. De Leenheer, and L. M. Thienpont
Standardization of C-Peptide Measurements in Urine by Method Comparison with Isotope-Dilution Mass Spectrometry
Clin. Chem., June 1, 2003; 49(6): 992 - 994.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
V. Marks
False-Positive Immunoassay Results: A Multicenter Survey of Erroneous Immunoassay Results from Assays of 74 Analytes in 10 Donors from 66 Laboratories in Seven Countries
Clin. Chem., November 1, 2002; 48(11): 2008 - 2016.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.